Antimicrobial Plastics Market Worth $43.1 Billion by 2023 - Exclusive Report by MarketsandMarkets™
26 mars 2019 à 15:30 UTC+1
SHARE THIS ARTICLE
Antimicrobial Plastics Market Worth $43.1 Billion by 2023 - Exclusive Report
Parx Plastics Gives Update on the Approval of its Patents in USA & China
ROTTERDAM, Netherlands -- May 29, 2019
Parx Plastics NV (Euronext: MLPRX) (“Parx” or the “Company”) is pleased to
update its investors on the approval of patents in the US and China.
The patenting process of the innovative technology developed by Parx Plastics
NV to make plastics antimicrobial by using a non-migrating biocompatible
element started off with a local patent in Italy together with a PCT
application. The Patent Cooperation Treaty (PCT) is an international patent
law treaty, concluded in 1970. It provides a unified procedure and priority
date for filing patents in each of its 152 contracting states. In the
PCT-period patents Parx Plastics has filed patents in different countries
amongst which USA and China.
Parx is very pleased to see now that these filings have been completely
finalised and granted. Receiving the official granting papers and certificates
concludes a pretty long application process for these territories. Securing
the technology for these territories is of great value to the company.
In particular the USA process has been one with communications back and
forward with the examiner explaining the technology and providing additional
research and tests building a strong case for the Parx application.
All efforts have led to a granted patent for USA and China, besides the
already granted patent applications in for example Canada and Italy. More
applications in more territories are still procedure, covering all together
more than 40 countries.
Vantage’s strategic partnerships with skilled writers, publishers, research
analysts and technology experts allows them to offer their portfolio of
clients over 40 years of progressive expertise in the marketing of public
companies. Vantage’s affiliation in financial media allows them to provide a
broad reach into the retail and institutional investor communities; this
includes dissemination of press releases to VC subscribers of Vantage which
includes Capital Managements (www.capital-managements.net), an Investor
Parx Plastics NV
Parx Plastics specializes in the development, manufacturing and marketing of
biocompatible plastics and antibacterial polymers. The company's technology
does not feature synthetic chemicals, biocides, heavy metals or nanoparticles.
It can be used with any type of plastic. It is fully biocompatible, non-toxic,
and does not diffuse out of the material. Also, it removes about 99% of
bacteria and microorganisms piling up on the surface of a product within 24
View source version on businesswire.com:
action en fixing,peu de volumes mais +145 pour cent en 1 an
consultation actualités, marché euronext access.
Message complété le 07/06/2019 13:05:45 par son auteur.
Aujourd hui +16% sur la semaine.70% depuis 1er janvier.ca monte assez bien.c du fixing à 11h30 et 16h30 et on a le temps sans se stresser de voir la valeur de l action à l ouverture.il y a du volume tous les jours et elle monte,elle monte.ca peu vouloir le coup de se faire de l argent en minimisant les risques par rapports aux autres actions.allez chercher l info sur l action sur internet et analysé les données !.